Deutsche Bank’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-56,996
| Closed | -$636K | – | 4711 |
|
|
2017
Q3 | $636K | Sell |
56,996
-253,803
| -82% | -$2.83M | ﹤0.01% | 3229 |
|
|
2017
Q2 | $3.42M | Buy |
310,799
+250,256
| +413% | +$2.75M | ﹤0.01% | 2173 |
|
|
2017
Q1 | $592K | Sell |
60,543
-13,227
| -18% | -$129K | ﹤0.01% | 2915 |
|
|
2016
Q4 | $795K | Sell |
73,770
-49,972
| -40% | -$539K | ﹤0.01% | 2808 |
|
|
2016
Q3 | $1.27M | Buy |
123,742
+18,580
| +18% | +$190K | ﹤0.01% | 2638 |
|
|
2016
Q2 | $1.37M | Sell |
105,162
-15,185
| -13% | -$198K | ﹤0.01% | 2635 |
|
|
2016
Q1 | $1.32M | Buy |
120,347
+94,209
| +360% | +$1.03M | ﹤0.01% | 2610 |
|
|
2015
Q4 | $239K | Sell |
26,138
-29,023
| -53% | -$265K | ﹤0.01% | 3507 |
|
|
2015
Q3 | $382K | Sell |
55,161
-45,204
| -45% | -$313K | ﹤0.01% | 3421 |
|
|
2015
Q2 | $985K | Buy |
100,365
+40,966
| +69% | +$402K | ﹤0.01% | 2923 |
|
|
2015
Q1 | $525K | Buy |
59,399
+25,927
| +77% | +$229K | ﹤0.01% | 3194 |
|
|
2014
Q4 | $292K | Buy |
33,472
+10,423
| +45% | +$90.9K | ﹤0.01% | 3902 |
|
|
2014
Q3 | $158K | Sell |
23,049
-31,588
| -58% | -$217K | ﹤0.01% | 3996 |
|
|
2014
Q2 | $287K | Buy |
54,637
+13,557
| +33% | +$71.2K | ﹤0.01% | 3750 |
|
|
2014
Q1 | $186K | Buy |
41,080
+10,549
| +35% | +$47.8K | ﹤0.01% | 3918 |
|
|
2013
Q4 | $153K | Sell |
30,531
-128,401
| -81% | -$643K | ﹤0.01% | 3815 |
|
|
2013
Q3 | $805K | Buy |
158,932
+84,893
| +115% | +$430K | ﹤0.01% | 3144 |
|
|
2013
Q2 | $367K | Buy |
+74,039
| New | +$367K | ﹤0.01% | 3358 |
|